Medy-Tox Inc.
Biopharmaceutical firm developing botulinum toxins, HA fillers, and dermocosmetics.
086900 | KO
Overview
Corporate Details
- ISIN(s):
- KR7086900008
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청원군 오창읍 각리1길 78 (주)메디톡스, 청원군
- Sector:
- Manufacturing
Description
Medy-Tox Inc. is a biopharmaceutical company focused on the research, development, and commercialization of biologic products. Its primary offerings are centered on botulinum toxin type A (BTX-A) formulations, including Neuronox®, INNOTOX®, Coretox®, and NEWLUX®, which are used for both aesthetic and therapeutic applications. The company is noted for developing the world's first liquid-injectable botulinum toxin. In addition to its toxin portfolio, Medy-Tox manufactures and markets a line of hyaluronic acid (HA) dermal fillers, such as Neuramis®, Atiere, and Potenfill. The company's product range also extends to dermocosmetics under the NEURADERM brand.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-09-24 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.7 KB | ||
| 2021-09-16 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 108.5 KB | ||
| 2021-09-14 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.8 KB | ||
| 2021-09-08 00:00 |
투자판단관련주요경영사항(애브비(AbbVie Inc.), 개선된 신경독소후보 제품(MT10109L) 권리반환 및 계약종료)
|
Korean | 6.1 KB | ||
| 2021-08-23 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.3 KB | ||
| 2021-08-13 00:00 |
반기보고서 (2021.06)
|
Korean | 1.5 MB | ||
| 2021-08-13 00:00 |
[기재정정]사업보고서 (2020.12)
|
Korean | 2.0 MB | ||
| 2021-08-13 00:00 |
[기재정정]분기보고서 (2021.03)
|
Korean | 1.3 MB | ||
| 2021-07-06 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 105.0 KB | ||
| 2021-07-06 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.9 KB | ||
| 2021-06-25 00:00 |
[기재정정]사업보고서 (2020.12)
|
Korean | 2.0 MB | ||
| 2021-06-22 00:00 |
기타경영사항(자율공시)(미국 국제무역위원회(US International Trade Commission, ITC)의 2020년 12월16일 최…
|
Korean | 5.9 KB | ||
| 2021-05-17 00:00 |
분기보고서 (2021.03)
|
Korean | 1.2 MB | ||
| 2021-04-30 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 123.1 KB | ||
| 2021-04-28 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 86.6 KB |
Automate Your Workflow. Get a real-time feed of all Medy-Tox Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Medy-Tox Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Medy-Tox Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
